Roche MS drug Ocrevus approved by FDA after 3-month delay
March 28, 2017 at 20:53 PM EDT
March 28 (Reuters) - The U.S. Food and Drug Administration (FDA) on Tuesday approved Roche Holding AG's multiple sclerosis (MS) drug Ocrevus, putting the potential blockbuster drug back on track after a delay by regulators over manufacturing issues.